Role of Clinical Pharmacists in Optimizing Patient Outcomes: An Updated Review

Authors

  • Waleed Mohammed Al-Otaibi
  • Saleh Mohammed Alghamdi
  • Mansour Rashed Alyami
  • Mohammed Rasheed Alotaibi
  • Abdualziz Ibrahim Alhazza

Keywords:

clinical pharmacists, medication therapy management, adverse drug reactions, medication adherence, interdisciplinary collaboration

Abstract

Clinical pharmacists play an important role in shaping patient outcomes and helping in the safe and effective use of the patients’ medications. Their role expands beyond the traditional responsibilities of a pharmacist, which involve the dispensing of medication at the community pharmacy. They participate in medication therapy management (MTM), which includes the prevention and management of adverse drug reactions (ADRs), promoting adherence to therapy, educating the patient, and designing individualized medication plans. They are also part of the inter-professional health care team. Clinical pharmacists assist in the identification and resolution of ADRs which are a significant threat to the safety of patients. ADRs are an example of an area where pharmacists can step in to assist patients and avert clinically significant adverse drug reactions. They also aid in understanding the medication prescribed and in the removal of barriers that hinder adherence to the treatment regimen and provide supportive counseling to patients to help them in the adherence to the treatment plan. They work together with physicians, nurses, and other members of the care team to align their medication-related decisions with the patients’ overall care plan in order to prevent medication-related problems and to maximize the positive outcomes of the care plan.

Downloads

Download data is not yet available.

References

[1] Lee JK, Alshehri S, Kutbi HI, Martin JR. Optimizing pharmacotherapy in elderly patients: the role of pharmacists. Integrated Pharmacy Research and Practice. 2015 Aug 11:101-11.

[2] Thorakkattil SA, Parakkal SA, Salim KM, Arain S, Krishnan G, Madathil H, Kuzhiyil AK, Aslam A, Abdulsalim S, Karuppannan M, Sridhar SB. Improving patient safety and access to healthcare: The role of pharmacist-managed clinics in optimizing therapeutic outcomes. Exploratory Research in Clinical and Social Pharmacy. 2024 Dec 1;16:100527.

[3] Graabæk T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic & clinical pharmacology & toxicology. 2013 Jun;112(6):359-73.

[4] Ensing HT, Stuijt CC, Van Den Bemt BJ, Van Dooren AA, Karapinar-Carkit F, Koster ES, Bouvy ML. Identifying the optimal role for pharmacists in care transitions: a systematic review. Journal of managed care & specialty pharmacy. 2015 Aug 1;21(8):614-38.

[5] Kale PD, Shedge VS, Sabale MV, Velhal AB, Jadhav PD, Redasani VK. Clinical Pharmacy and Therapeutics: Enhancing Patient Care and Outcomes. Advances in Pharmaceutical Research Authors Name: Dr. MG Maniyar and Dr. AV Landge.:13.

[6] Devine EB, Hoang S, Fisk AW, Wilson-Norton JL, Lawless NM, Louie C. Strategies to optimize medication use in the physician group practice: the role of the clinical pharmacist. Journal of the American Pharmacists Association. 2009 Mar 1;49(2):181-91.

[7] Kumar RS. Pharmacotherapy and the Critical Role of Pharmacists in Rehabilitation Medicine. Pharmacotherapy. 2024 Jun;1(1).

[8] Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL, Bittner V, Walsh MN. The role of the clinical pharmacist in the care of patients with cardiovascular disease. Journal of the American College of Cardiology. 2015 Nov 10;66(19):2129-39.

[9] Urbańczyk K, Guntschnig S, Antoniadis V, Falamic S, Kovacevic T, Kurczewska-Michalak M, Miljković B, Olearova A, Sviestina I, Szucs A, Tachkov K. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in pharmacology. 2023 Aug 2;14:1244151.

[10] Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010). International journal of clinical pharmacy. 2015 Oct;37(5):687-97.

[11] Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Archives of internal medicine. 2006 May 8;166(9):955-64.

[12] Zavaleta-Monestel E, Arguedas-Chacón S, Quirós-Romero A, Chaverri-Fernández JM, Serrano-Arias B, Díaz-Madriz JP, García-Montero J, Speranza-Sanchez MO. Optimizing heart failure management: a review of the clinical pharmacist integration to the multidisciplinary health care team. International journal of heart failure. 2023 Nov 15;6(1):1.

[13] Ahmed A, Saqlain M, Tanveer M, Blebil AQ, Dujaili JA, Hasan SS. The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review. BMC health services research. 2021 Aug 23;21(1):859.

[14] Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs & aging. 2012 Jun;29(6):495-510.

[15] Newman TV, Hernandez I, Keyser D, San-Juan-Rodriguez A, Swart EC, Shrank WH, Parekh N. Optimizing the role of community pharmacists in managing the health of populations: barriers, facilitators, and policy recommendations. Journal of managed care & specialty pharmacy. 2019 Sep;25(9):995-1000.

[16] Naseralallah L, Koraysh S, Alasmar M, Aboujabal B. Effect of pharmacist care on clinical outcomes and therapy optimization in perioperative settings: A systematic review. American Journal of Health-System Pharmacy. 2025 Jan 1;82(1):44-73.

[17] American College of Clinical Pharmacy, Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, DO Burkhardt C, Schilli K, Seaton T. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012 Nov;32(11):e326-37.

[18] Ahlawat A, Jangid R, Sharma S, Rathee S, Parashar I, Wadhawan R. Enhancing Patient Care with Teledentistry and Smart Diagnostic Tools: A Review. Oral Sphere J. Dent. Health Sci. 2025;1(2):116-122. https://doi.org/10.63150/osjdhs.2025.08

[19] Schreier DJ, Lovely JK. Optimizing clinical monitoring tools to enhance patient review by pharmacists. Applied Clinical Informatics. 2021 May;12(03):621-8.

[20] Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management services: definitions and outcomes. Drugs. 2009 Mar;69(4):393-406.

[21] Burns A. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). Journal of the American Pharmacists Association. 2008 May 1;48(3):341-53.

[22] Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. Journal of the American Pharmacists Association. 2008 Mar 1;48(2):203-14.

[23] Bhat R, Bhandary A, Karicheri , Palakki G, Uday M. Antibody-Drug Conjugates: Advances and Applications in Targeted Cancer Therapies. Oral Sphere J. Dent. Health Sci. 2025;1(2):63-72. https://doi.org/10.63150/osjdhs.2025.3

[24] Zekan L, Mestrovic A, Perisin AS, Bukic J, Leskur D, Rusic D, Modun D. Improving community pharmacists’ clinical knowledge to detect and resolve drug-related problems in Croatia: a before/after survey study investigating the efficacy of an educational intervention. BMJ open. 2020 Jun 1;10(6):e034674.

[25] Sah SK, Ramaswamy S, Ramesh M. Impact of clinical pharmacist interventions in resolving drug-related problems in patients with systemic autoimmune disorders. Journal of Pharmacology and Pharmacotherapeutics. 2021 Dec;12(4):168-71.

[26] Elkalmi RM, Hassali MA, Ibrahim MI. Impact of educational intervention for improving pharmacist knowledge in adverse drug reactions (ADR) reporting: experience from Malaysia. Open Drug Saf J. 2011 Jul 28;2(1):47-53.

[27] Dagnew SB, Binega Mekonnen G, Gebeye Zeleke E, Agegnew Wondm S, Yimer Tadesse T. Clinical pharmacist intervention on drug‐related problems among elderly patients admitted to medical wards of Northwest Ethiopia comprehensive specialized hospitals: a multicenter prospective, observational study. BioMed Research International. 2022;2022(1):8742998

[28] Nguyen KA, Militello LG, Ifeachor A, Arthur KJ, Glassman PA, Zillich AJ, Weiner M, Russ-Jara AL. Strategies prescribers and pharmacists use to identify and mitigate adverse drug reactions in inpatient and outpatient care: a cognitive task analysis at a US veterans affairs medical center. BMJ open. 2022 Feb 1;12(2):e052401.

[29] Shahrami B, Sefidani Forough A, Najmeddin F, Hadidi E, Toomaj S, Javadi MR, Gholami K, Sadeghi K. Identification of drug‐related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. Journal of Clinical Pharmacy and Therapeutics. 2022 Jul;47(7):964-72.

[30] Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC geriatrics. 2020 Jan 13;20(1):13.

[31] Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug‐related problems. Journal of clinical pharmacy and therapeutics. 2009 Jun;34(3):319-27.

[32] Shahrami B, Alimadadi M, Rahimi S, Abutalebzadeh M, Tayefeh S, Kaveh-Ahangaran R, Najmeddin F, Hadidi E. Identification and Resolution of Drug‐Related Problems by Clinical Pharmacist Interventions in an Occupational Health Setting: A Study on Pharmacy Staff. Journal of Clinical Pharmacy and Therapeutics. 2025;2025(1):5540546.

[33] Zaij S, Pereira Maia K, Leguelinel-Blache G, Roux-Marson C, Kinowski JM, Richard H. Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review. BMC Health Services Research. 2023 Aug 30;23(1):927.

[34] O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Gallagher J, Cullinan S, O’Sullivan R, Eustace J, Byrne S. Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial. Drugs & aging. 2016 Jan;33(1):63-73.

[35] Greeshma M, Lincy S, Maheswari E, Tharanath S, Viswam S. Identification of drug related problems by clinical pharmacist in prescriptions with polypharmacy: a prospective interventional study. Journal of Young Pharmacists. 2018;10(4):460.

[36] Reeves JA, Francis SA. A comparison between two methods of teaching hospital pharmacists about adverse drug reactions: problem-based learning versus a didactic lecture. Pharmacy education. 2001;1(1).

[37] Lan T, Wang H, Li X, Yin H, Shao D, Jiang Y, Yu Q. The effect of clinical pharmacists’ intervention in adverse drug reaction reporting: a retrospective analysis with a 9-year interrupted time series. BMC Health Services Research. 2022 Jul 19;22(1):925.

[38] Jamal I, Amin F, Jamal A, Saeed A. Pharmacist s interventions in reducing the incidences of drug related problems in any practice setting. International current pharmaceutical journal. 2015 Jan 7;4(2):347-52.

[39] McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. Journal of the American Pharmacists Association. 2003 Jul 1;43(4):511-8.

[40] SANTOS NS, LOPES DS, SANTANA TB, MASCARENHAS AS, MOREIRA-REIS AM, LEMOS GS. Clinical pharmacist interventions in a hospital emergency. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 2022 Mar 23;13(1):731-.

[41] Gökçekuş L, Mestrovic A, Basgut B. Pharmacist intervention in drug-related problems for patients with cardiovascular diseases in selected community pharmacies in Northern Cyprus. Tropical Journal of Pharmaceutical Research. 2016 Nov 14;15(10):2275-81.

[42] Sharick Shamsi, Faisal M Alyazedi, Samiha Mohamed Abdelkader, Shabana Khan, Ali Akhtar, Efficacy of sustained natural apophyseal glides in the management of mechanical neck pain: a randomized clinical trial, Indian Journal of Medical Specialities, 2021;12:4:199-206..

Downloads

Published

2025-06-18

How to Cite

1.
Al-Otaibi WM, Alghamdi SM, Alyami MR, Alotaibi MR, Alhazza AI. Role of Clinical Pharmacists in Optimizing Patient Outcomes: An Updated Review. J Neonatal Surg [Internet]. 2025 Jun. 18 [cited 2026 Apr. 14];14(32S):10406-13. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9924

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.